PubMed Health⌕ Search

Biomedical subjects

T Cresteil

Publications and source records attributed to T Cresteil.

74 records · Page 5Linked to original sources

Metabolism of ketotifen by human liver microsomes. In vitro characterization of a tertiary amine glucuronidation.

Biotransformation of ketotifen was investigated in vitro using human liver microsomes. Three of the four metabolic pathways observed in vivo in man were exhibited under the conditions of incubation, namely demethylation, N-oxidation, and N-glucuronidation, the absent route being the ketoreduction, which probably has a cytosolic localization. The kinetic parameters of the N-glucuronidation (KM for ketotifen and UDPGA and Vmax) were determined with native and detergent-treated microsomes. Treatment by Triton X-100 increased by about 3-fold the conjugation reaction. No sex difference was observed and N-glucuronidation did not seem to be inhibited either by bilirubin or by 4-nitrophenol. Thus, human liver microsomes are a useful and suitable in vitro model for studying metabolic routes, specific for man, as in the case of ketotifen. Obviously, the results obtained can only reflect partially the multiplicity of in vivo events and interpretation has to be complemented by investigations with other models.

Bilirubin↗

[Role of monoxygenases in the metabolism of drugs in the human fetus and newborn infant].

Drug-metabolizing enzyme activities were assayed in human fetuses and neonates and compared with activities in adults. Among these enzymes, only UDP-glucuronosyltransferase exhibited a very low activity, whereas cytochromes P-450, epoxide hydrolase and glutathion S-transferase reached about 50% of adult values as soon as 15-20 weeks of gestational age. Multiple cytochromes P-450 were present in human adults: isoenzymes involved in the metabolism of exogenous substrates such as ethylmorphine, hexobarbital, aniline and diazepam, and endogenous substrates were present and active in the fetus, whereas isoenzyme(s) permitting the hydroxylation of polycyclic aromatic hydrocarbons exhibited a very low activity. A low number of transplacental inductions have been enzymatically studied; only correlations between the pharmacokinetics of a drug in neonates (full-term or premature) and drug intake of the mother during gestation were observed and showed that a treatment with barbiturates significantly increased drug elimination in neonates. Thus, in human fetus and neonate, drug-metabolizing enzymes are present and active, except UDP-glucuronosyltransferase which develops only after birth.

Adult↗